Radjin Steingrover

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. doi HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy
    Radjin Steingrover
    Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, and Center for Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
    AIDS 22:1583-8. 2008
  2. doi Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection
    Radjin Steingrover
    Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, and Center for Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
    AIDS Res Hum Retroviruses 26:379-87. 2010
  3. pmc No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial
    Marlous L Grijsen
    Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    PLoS Med 9:e1001196. 2012
  4. ncbi Viral dynamics after starting first-line HAART in HIV-1-infected children
    Vincent Bekker
    Emma Children s Hospital, Academic Medical Center, The Netherlands
    AIDS 20:517-23. 2006
  5. doi Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection
    Mireille Centlivre
    Laboratories of Experimental Virology, Department of Medical Microbiology, Center for Infection andImmunity Amsterdam, Tropical Medicine and AIDS, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands
    J Leukoc Biol 89:785-95. 2011
  6. ncbi A sudden rise in viral load is infrequently associated with HIV-1 superinfection
    Suzanne Jurriaans
    Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam CINIMA, Amsterdam, The Netherlands
    J Acquir Immune Defic Syndr 47:69-73. 2008
  7. doi High prevalence of reduced bone mineral density in primary HIV-1-infected men
    Marlous L Grijsen
    Academic Medical Center, University of Amsterdam, Department of Internal Medicine, The Netherlands
    AIDS 24:2233-8. 2010
  8. ncbi Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions
    Christine A Jansen
    Department of Clinical Viro Immunology, Sanquin Research and Landsteiner Laboratory, University of Amsterdam, The Netherlands
    AIDS 19:1145-54. 2005
  9. ncbi Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging
    Nienke Vrisekoop
    Department of Immunology, University Medical Center, Utrecht, The Netherlands
    J Immunol 181:1573-81. 2008

Collaborators

Detail Information

Publications9

  1. doi HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy
    Radjin Steingrover
    Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, and Center for Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
    AIDS 22:1583-8. 2008
    ....
  2. doi Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection
    Radjin Steingrover
    Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, and Center for Infection and Immunity Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
    AIDS Res Hum Retroviruses 26:379-87. 2010
    ..Temporary HAART in PHI is started more frequently in patients with a higher pVL and can transiently lower the viral set point compared to never treated patients...
  3. pmc No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial
    Marlous L Grijsen
    Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    PLoS Med 9:e1001196. 2012
    ..The objective of this study was to assess the benefit of temporary combination antiretroviral therapy (cART) during primary HIV infection (PHI)...
  4. ncbi Viral dynamics after starting first-line HAART in HIV-1-infected children
    Vincent Bekker
    Emma Children s Hospital, Academic Medical Center, The Netherlands
    AIDS 20:517-23. 2006
    ..Therefore viral decay and time to reach a pVL of < 400 copies/ml during the first weeks after starting HAART were studied in a cohort of HIV-1-infected children...
  5. doi Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection
    Mireille Centlivre
    Laboratories of Experimental Virology, Department of Medical Microbiology, Center for Infection andImmunity Amsterdam, Tropical Medicine and AIDS, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands
    J Leukoc Biol 89:785-95. 2011
    ..Overall, our results demonstrate that non-T cell compartments are a major HIV-1 DNA reservoir, and CD16(+) monocytes and CD16(+) cDCs potentially play an important role in HIV-1 dissemination...
  6. ncbi A sudden rise in viral load is infrequently associated with HIV-1 superinfection
    Suzanne Jurriaans
    Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam CINIMA, Amsterdam, The Netherlands
    J Acquir Immune Defic Syndr 47:69-73. 2008
    ....
  7. doi High prevalence of reduced bone mineral density in primary HIV-1-infected men
    Marlous L Grijsen
    Academic Medical Center, University of Amsterdam, Department of Internal Medicine, The Netherlands
    AIDS 24:2233-8. 2010
    ..To assess the bone mineral density (BMD) in a cohort of men with primary HIV-1 infection (PHI)...
  8. ncbi Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions
    Christine A Jansen
    Department of Clinical Viro Immunology, Sanquin Research and Landsteiner Laboratory, University of Amsterdam, The Netherlands
    AIDS 19:1145-54. 2005
    ..It has been reported that antiretroviral therapy (HAART) during acute HIV-1 infection may rescue HIV-1-specific CD4 T cell responses...
  9. ncbi Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging
    Nienke Vrisekoop
    Department of Immunology, University Medical Center, Utrecht, The Netherlands
    J Immunol 181:1573-81. 2008
    ..Irrespective of baseline CD4 T cell counts, reconstitution occurred without a significant effect on T cell aging as reflected by markers for replicative history...